BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 17274819)

  • 1. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
    Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
    Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
    Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH
    PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
    Cools M; Stoop H; Kersemaekers AM; Drop SL; Wolffenbuttel KP; Bourguignon JP; Slowikowska-Hilczer J; Kula K; Faradz SM; Oosterhuis JW; Looijenga LH
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2404-13. PubMed ID: 16608895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers.
    Hoei-Hansen CE; Sehested A; Juhler M; Lau YF; Skakkebaek NE; Laursen H; Rajpert-de Meyts E
    J Pathol; 2006 May; 209(1):25-33. PubMed ID: 16456896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
    Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
    Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for the presence of oogonia in the human ovary after their final clearance during the first two years of life.
    Byskov AG; Høyer PE; Yding Andersen C; Kristensen SG; Jespersen A; Møllgård K
    Hum Reprod; 2011 Aug; 26(8):2129-39. PubMed ID: 21572085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY.
    Vogt PH; Besikoglu B; Bettendorf M; Frank-Herrmann P; Zimmer J; Bender U; Knauer-Fischer S; Choukair D; Sinn P; Lau YC; Heidemann PH; Strowitzki T
    Hum Reprod; 2019 Apr; 34(4):770-779. PubMed ID: 30753444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours.
    Hoei-Hansen CE; Almstrup K; Nielsen JE; Brask Sonne S; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
    Histopathology; 2005 Jul; 47(1):48-56. PubMed ID: 15982323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis of bilateral ovarian germ cell tumors.
    Hennes E; Zahn S; Lopes LF; Schönberger S; Leuschner I; Göbel U; Calaminus G; Schneider DT
    Klin Padiatr; 2012 Oct; 224(6):359-65. PubMed ID: 23143763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
    Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
    Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
    Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
    Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel double staining strategy for improved detection of testicular carcinoma in situ cells in human semen samples.
    Nielsen JE; Kristensen DM; Almstrup K; Jørgensen A; Olesen IA; Jacobsen GK; Horn T; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
    Andrologia; 2012 Apr; 44(2):78-85. PubMed ID: 21486421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-KIT codon 816 mutation in a recurrent and metastatic dysgerminoma of a 14-year-old girl: case study.
    Pauls K; Wardelmann E; Merkelbach-Bruse S; Büttner R; Zhou H
    Virchows Arch; 2004 Dec; 445(6):651-4. PubMed ID: 15455230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors.
    Pauls K; Jäger R; Weber S; Wardelmann E; Koch A; Büttner R; Schorle H
    Int J Cancer; 2005 Jun; 115(3):470-7. PubMed ID: 15700319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers.
    Hoei-Hansen CE; Carlsen E; Jorgensen N; Leffers H; Skakkebaek NE; Rajpert-De Meyts E
    Hum Reprod; 2007 Jan; 22(1):167-73. PubMed ID: 16920726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant ovarian germ cell tumours in gonadal Y chromosome mosaicism.
    Shahsiah R; Jahanbin B; Rabiei R; Ardalan FA; Sarhadi B; Izadi-Mood N
    J Clin Pathol; 2011 Nov; 64(11):973-6. PubMed ID: 21752796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors.
    Hart AH; Hartley L; Parker K; Ibrahim M; Looijenga LH; Pauchnik M; Chow CW; Robb L
    Cancer; 2005 Nov; 104(10):2092-8. PubMed ID: 16206293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor risk in disorders of sex development (DSD).
    Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
    Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
    Rajpert-De Meyts E
    Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadoblastoma: evidence for a stepwise progression to dysgerminoma in a dysgenetic ovary.
    Pauls K; Franke FE; Büttner R; Zhou H
    Virchows Arch; 2005 Sep; 447(3):603-9. PubMed ID: 15968543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.